PCM
AMRI

Proxima Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Proxima Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-49,755
Closed -$1.08M – 42
2017
Q2 		$1.08M Buy
+49,755
New +$903K 0.59% 34

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Proxima Capital Management's AMRI Position: Q3 2017 in Review

Proxima Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 49,755 shares — an estimated $1.08M sold.

Proxima Capital Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $1.08M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Proxima Capital Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Proxima Capital Management sold 49,755 Albany Molecular Research Inc shares in Q3 2017, an estimated $1.08M.
  • Proxima Capital Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Proxima Capital Management's Albany Molecular Research Inc position peaked at $1.08M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Proxima Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.